Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, William A. Wood, Marcelo C. Pasquini et al.|Blood|2017Cited by 296
Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignanciesRobert Stuver, Santosha A. Vardhana, Lorenzo Falchi et al.|Cancer Cell|2022Cited by 88
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsMichael A. Pulsipher, Thomas R. Spitzer, Brent R. Logan et al.|Haematologica|2018Cited by 22
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety StudyMichael A. Pulsipher, Shalini Shenoy, Brent R. Logan et al.|Biology of Blood and Marrow Transplantation|2018Cited by 19